Get startedLog in
    Picture of Cerevel Therapeutics Holdings logo

    CERE — Cerevel Therapeutics Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study

    Picture of Cerevel Therapeutics Holdings logoCerevel Therapeutics Holdings
    18/04/2024 11:36
    April 18 (Reuters) - Cerevel Therapeutics  CERE.O  said
on Thursday its Parkinson's disease drug met the main goal of a
late-stage trial.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Savio
D'Souza)
 ((Sriparna.Roy@thomsonreuters.com;))

    Recent news on Cerevel Therapeutics Holdings

    See all news